共 136 条
- [1] Forner A(2018)Hepatocellular carcinoma Lancet 391 1301-1314
- [2] Reig M(2022)BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update J Hepatol 76 681-693
- [3] Bruix J(2017)Meta-analysis of determinants of survival following treatment of recurrent hepatocellular carcinoma Br J Surg 104 1433-1442
- [4] Reig M(2021)Surgery for Recurrent Hepatocellular Carcinoma: Achieving Long-term Survival Ann Surg 273 792-799
- [5] Forner A(2012)EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma J Hepatol 56 908-943
- [6] Rimola J(2011)Management of hepatocellular carcinoma: an update Hepatology 53 1020-2
- [7] Ferrer-Fabrega J(2021)Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update Liver Cancer 10 181-223
- [8] Burrel M(2015)Surgical results for recurrent hepatocellular carcinoma after curative hepatectomy: Repeat hepatectomy versus salvage living donor liver transplantation Liver Transpl 21 961-968
- [9] Garcia-Criado A(2022)Salvage living donor liver transplantation versus repeat liver resection for patients with recurrent hepatocellular carcinoma and Child-Pugh class A liver cirrhosis: A propensity score-matched comparison Am J Transplant 22 165-176
- [10] Erridge S(2017)Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: An intent-to-treat analysis Liver Transpl 23 1553-1563